Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Hiroshi Kasugai"'
Autor:
Hiroyasu Imanishi, Shuhei Nishiguchi, Akira Muramatsu, Yoshinori Iwata, Hiroshi Kasugai, Yoshihiko Yano, Hirayuki Enomoto, Susumu Imoto, Hiroaki Okushin, Hideji Nakamura, Yasushi Seo, Toshiaki Ninomiya, Hiroko Iijma, Soji Shimomura, Tomoyuki Takashima, Teruji Ooka, Masahiko Sugano, Masaki Saito, Michiko Shindo, Soo Ryang Kim, Hisato Jomura, Nobuhiro Aizawa
Publikováno v:
Hepatology Research. 44:597-607
Aim The recommended treatment for chronic hepatitis C is a combination of pegylated interferon (PEG IFN) plus ribavirin (RBV). However, the sustained virological response (SVR) rate of PEG IFN-RBV therapy was approximately 50% in patients with genoty
Autor:
Haruhiko Yoshida, Masao Omata, Ryoko Kuromatsu, Tetsuo Katamoto, Tatsuya Yamashita, Yukihiro Koike, Yoshiyuki Ueno, Kyosuke Yamamoto, Naohiko Masaki, Kunihiko Tsuji, Hiroko Oka, Takao Kawabe, Akihisa Ishikawa, Toshiya Osawa, Isao Sakaida, Yasuyuki Araki, Toshihiko Mizuta, Minoru Nomoto, Masamichi Kojiro, Hidekatsu Kuroda, Shuichiro Shiina, Kentaro Kikuchi, Namiki Izumi, Masataka Seike, Kazumi Tagawa, Kenichi Saito, Hiroshi Ikeda, Nozomu Koyanagi, Haruhiko Kobashi, Shotaro Sakisaka, Hiroshi Kasugai, Joji Toyota, Seiji Kawazoe, Masao Ichinose, Toshihito Seki, Yukio Osaki, Yasushi Shiratori, Hiroyuki Kokuryu, Masatoshi Kudo
Publikováno v:
Hepatology. 54:532-540
Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, even after curative treatment. Vitamin K2, which has been reported to reduce HCC development, may be effective in preventing HCC recurrence. Patients who underwent curative ablat
Autor:
Masanori Sakashita, Yoshiaki Nagata, Akira Nakamura, Masahiko Sugano, Akira Muramatsu, Soo Ryang Kim, Masatoshi Kudo, Susumu Imoto, Tetsuya Makino, Takamitsu Komaki, Takatoshi Nakajima, Erika Konishi, Shinobu Tsuchida, Hiroshi Kasugai, Yutaka Hasegawa, Noriko Sasase, Jun Saito, Kanako Sasatani, Tetsumi Kawada, Aya Fujinami, Ke Ih Kim, Ahmed El-Shamy, Yasuhito Tanaka, Hak Hotta, Teruhisa Morikawa, Noriyo Kimura, Mitsuhiro Ohta
Publikováno v:
Digestion. 84:10-16
Background and Aims: Double-filtration plasmapheresis (DFPP) together with interferon (IFN) administration produces a substantial reduction in the viral load during the early stages of treatment. Methods: Based on their responses to previous pegylate
Autor:
Hidenori Yoshie, Hiroya Iida, Naoki Yamanaka, Masao Mitsunobu, Katsuichi Kikuchi, Hiroshi Kasugai, Tsukasa Aihara, Hidenori Yanagi, Chiaki Yasui, Keita Ogake, Yoshiyuki Ishikura, Takeshi Harada, Shinichi Ikuta
Publikováno v:
Kanzo. 52:361-367
我々は経皮的ラジオ波焼灼療法(以下,RFAと略記)後に対極板貼付部の皮膚にII度の熱傷を生じた症例を経験した.当症例は焼灼中モニタリングしていた組織インピーダンス(以下,IMP
Autor:
Seiichiro Yamamoto, Hiroshi Kasugai, Tosiya Sato, Shigetoshi Fujiyama, Yasukazu Shioyama, Keiko Sato, Shiro Hinotsu, Takashi Kumada, Takuji Okusaka, Masatoshi Kudo, Yukio Osaki, Hiromitsu Saisho, Katsuaki Tanaka, Michio Sata
Publikováno v:
Journal of Hepatology. 51:1030-1036
Background/Aims Transcatheter arterial chemoembolization (TACE) is a combination of transarterial infusion chemotherapy (TAI) and embolization, and has been widely used to treat patients with hepatocellular carcinoma (HCC). However, since the impact
Diagnostic Accuracy of Imaging for Liver Cirrhosis Compared to Histologically Proven Liver Cirrhosis
Autor:
Kazuhide Shimamatsu, Toshinao Itani, Norio Usuki, Masamichi Kojiro, Masayuki Kanematsu, Masayoshi Kage, Yukio Osaki, Masatoshi Kudo, Soo Ryang Kim, Rong Qin Zheng, Yoshihiro Okabe, Hiroshi Kasugai, Katsuyoshi Ito, Hiroko Iijima
Publikováno v:
Intervirology. 51:17-26
Objective: To evaluate the diagnostic accuracy of liver cirrhosis by imaging modalities, including CT, MRI and US, compared to results obtained from histopathological diagnoses of resected specimens. Materials and Methods: CT, MRI and US examinations
Autor:
Hiroshi Kasugai, Yo Sasaki, Hiroko Oka, Takashi Matsunaga, Masatoshi Kudo, Yasunori Minami, Seiji Haji, Satoshi Kitai, Toshihito Seki, Yukio Osaki
Publikováno v:
Oncology. 75:83-90
Objectives: The conventional Japan Integrated Staging (c-JIS) score has been reported to effectively stratify patients with hepatocellular carcinoma (HCC). Recently, two new staging systems, the biomarker-combined JIS (bm-JIS) score and the BALAD sco
Autor:
Hiroko Oka, Yukio Osaki, Yo Sasaki, Hobyung Chung, Masatoshi Kudo, Seiji Haji, Hiroshi Kasugai, Toshihito Seki
Publikováno v:
Hepatology Research. 34:124-129
Objective The purpose of this study was to evaluate the validity of the two common classifications for assessing liver function; the Child-Pugh classification and the liver damage classification. We also examined the feasibility of the modified liver
Autor:
Yo Sasaki, Terumasa Yamada, Hiroaki Ohigashi, Hidetoshi Eguchi, Kentaro Kishi, Shingo Noura, Koh Takachi, Isao Miyashiro, Masayuki Ohue, Masahiko Yano, Osamu Ishikawa, Hiroshi Kasugai, Atsuo Inoue, Shingi Imaoka
Publikováno v:
Journal of Microwave Surgery. 23:19-24
Autor:
Akiko Saito, Kazuki Ito, Shinji Satomura, Hiroshi Kasugai, Masatoshi Kudo, Takashi Kumada, Hiroko Oka, M. Tanaka, Yukio Osaki, Toshihito Seki
Publikováno v:
Journal of Gastroenterology and Hepatology. 16:1378-1383
Background and Aim: The Lens culinaris agglutinin-reactive fraction of α-fetoprotein (AFP-L3) has been reported to be a highly useful marker for hepatocellular carcinoma (HCC) compared with a conventional serum AFP concentration, which allows earlie